These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28406980)

  • 1. Correction: Tensor based multichannel reconstruction for breast tumours identification from DCE-MRIs.
    Yin XX; Hadjiloucas S; Chen JH; Zhang Y; Wu JL; Su MY
    PLoS One; 2017; 12(4):e0176133. PubMed ID: 28406980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tensor based multichannel reconstruction for breast tumours identification from DCE-MRIs.
    Yin XX; Hadjiloucas S; Chen JH; Zhang Y; Wu JL; Su MY
    PLoS One; 2017; 12(3):e0172111. PubMed ID: 28282379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Discrimination of breast cancer from benign tumours using Raman spectroscopy.
    Lyng FM; Traynor D; Nguyen TNQ; Meade AD; Rakib F; Al-Saady R; Goormaghtigh E; Al-Saad K; Ali MH
    PLoS One; 2019; 14(4):e0216311. PubMed ID: 31022278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Smartphone dependence classification using tensor factorization.
    PLOS ONE Staff
    PLoS One; 2017; 12(9):e0185506. PubMed ID: 28934334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Tensor decomposition-based unsupervised feature extraction applied to matrix products for multi-view data processing.
    Taguchi YH
    PLoS One; 2018; 13(7):e0200451. PubMed ID: 30020990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Preliminary Study of MR Diffusion Tensor Imaging of Pancreas for the Diagnosis of Acute Pancreatitis.
    Li X; Zhuang L; Zhang X; Wang J; Chen T; Li L; Aduah EA; Hu J
    PLoS One; 2016; 11(10):e0165353. PubMed ID: 27760203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Community ecology in 3D: Tensor decomposition reveals spatio-temporal dynamics of large ecological communities.
    Frelat R; Lindegren M; Dencker TS; Floeter J; Fock HO; Sguotti C; Stäbler M; Otto SA; Möllmann C
    PLoS One; 2018; 13(4):e0196353. PubMed ID: 29672602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
    Costa-Cabral S; Brough R; Konde A; Aarts M; Campbell J; Marinari E; Riffell J; Bardelli A; Torrance C; Lord CJ; Ashworth A
    PLoS One; 2017; 12(4):e0176578. PubMed ID: 28426773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: DCE-MRI-Derived Parameters in Evaluating Abraxane-Induced Early Vascular Response and the Effectiveness of Its Synergistic Interaction with Cisplatin.
    Sun X; Yang L; Yan X; Sun Y; Zhao D; Ji Y; Wang K; Chen X; Shen B
    PLoS One; 2023; 18(8):e0290861. PubMed ID: 37624828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Soleus muscle weakness in cerebral palsy: Muscle architecture revealed with Diffusion Tensor Imaging.
    Sahrmann AS; Stott NS; Besier TF; Fernandez JW; Handsfield GG
    PLoS One; 2020; 15(6):e0234582. PubMed ID: 32502220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
    Costa-Cabral S; Brough R; Konde A; Aarts M; Campbell J; Marinari E; Riffell J; Bardelli A; Torrance C; Lord CJ; Ashworth A
    PLoS One; 2018; 13(10):e0206729. PubMed ID: 30365555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Anatomical analysis of antebrachial cutaneous nerve distribution pattern and its clinical implications for sensory reconstruction.
    PLOS ONE Staff
    PLoS One; 2019; 14(10):e0223916. PubMed ID: 31600348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: galectin-3 as a marker and potential therapeutic target in breast cancer.
    PLOS ONE Staff
    PLoS One; 2015; 10(1):e0116994. PubMed ID: 25621883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: breast cancer screening in Saudi Arabia: free but almost no takers.
    PLOS ONE Staff
    PLoS One; 2015; 10(4):e0124850. PubMed ID: 25853811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer.
    Bennani-Baiti B; Dietzel M; Baltzer PA
    PLoS One; 2016; 11(9):e0162936. PubMed ID: 27607428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.
    Lee YH; Liu X; Qiu F; O'Connor TR; Yen Y; Ann DK
    PLoS One; 2015; 10(4):e0124853. PubMed ID: 25875848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer.
    Goode G; Gunda V; Chaika NV; Purohit V; Yu F; Singh PK
    PLoS One; 2017; 12(6):e0179098. PubMed ID: 28570622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Prime incision: A minimally invasive approach to breast cancer surgical treatment-A 2 cohort retrospective comparison with conventional breast conserving surgery.
    Bromberg SE; Moraes PRAF; Ades F
    PLoS One; 2018; 13(3):e0195130. PubMed ID: 29579107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer.
    Li T; Zhao J; Yang J; Ma X; Dai Q; Huang H; Wang L; Liu P
    PLoS One; 2018; 13(1):e0191579. PubMed ID: 29342211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.
    PLOS ONE Staff
    PLoS One; 2017; 12(3):e0174493. PubMed ID: 28301577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.